JP2011514167A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011514167A5 JP2011514167A5 JP2011500189A JP2011500189A JP2011514167A5 JP 2011514167 A5 JP2011514167 A5 JP 2011514167A5 JP 2011500189 A JP2011500189 A JP 2011500189A JP 2011500189 A JP2011500189 A JP 2011500189A JP 2011514167 A5 JP2011514167 A5 JP 2011514167A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- functionally active
- active variant
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 101710194807 Protective antigen Proteins 0.000 claims 3
- 230000003308 immunostimulating effect Effects 0.000 claims 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 229920002851 polycationic polymer Polymers 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- RBEATVHTWHTHTJ-KKUMJFAQSA-N Lys-Leu-Lys Chemical group NCCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O RBEATVHTWHTHTJ-KKUMJFAQSA-N 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 229940037003 alum Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08102655 | 2008-03-17 | ||
| PCT/EP2009/053119 WO2009115508A2 (en) | 2008-03-17 | 2009-03-17 | Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011514167A JP2011514167A (ja) | 2011-05-06 |
| JP2011514167A5 true JP2011514167A5 (enExample) | 2012-04-05 |
Family
ID=40673589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500189A Pending JP2011514167A (ja) | 2008-03-17 | 2009-03-17 | 肺炎連鎖球菌（Ｓ．ｐｎｅｕｍｏｎｉａｅ）に対して保護的なペプチドならびにそれに関連する組成物、方法、および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8241643B2 (enExample) |
| EP (1) | EP2265634A2 (enExample) |
| JP (1) | JP2011514167A (enExample) |
| CN (1) | CN101977927A (enExample) |
| AU (1) | AU2009226949A1 (enExample) |
| BR (1) | BRPI0909664A2 (enExample) |
| CA (1) | CA2718473A1 (enExample) |
| WO (1) | WO2009115508A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009226949A1 (en) | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| WO2015054515A1 (en) * | 2013-10-09 | 2015-04-16 | University Of Rochester | Chips, detection systems, and methods for multiplex pneumococcus serology |
| CN105963691B (zh) * | 2016-07-03 | 2020-05-01 | 查文娟 | 一种肺炎链球菌疫苗 |
| EP4377329A1 (en) * | 2021-07-29 | 2024-06-05 | Université de Lausanne | Novel pneumococcal polypeptide antigens |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| WO1991018088A1 (en) | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
| US5854416A (en) | 1991-11-14 | 1998-12-29 | The United States Of America As Represented By The Department Of Health And Human Services | Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor |
| CA2560114A1 (en) | 1994-07-15 | 1996-02-01 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| US7153952B1 (en) * | 1997-07-02 | 2006-12-26 | sanofi pasteur limited/sanofi pasteur limitée | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| WO2000006738A2 (en) * | 1998-07-27 | 2000-02-10 | Microbial Technics Limited | NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| AT409085B (de) | 2000-01-28 | 2002-05-27 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen |
| ATE375169T1 (de) | 2000-04-14 | 2007-10-15 | Intercell Ag | Modifizierte peptide enthaltende pharmazeutische präparationen |
| HU228264B1 (en) | 2000-06-08 | 2013-02-28 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| CA2418854A1 (en) | 2000-08-17 | 2002-02-21 | Jorg Fritz | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0107658D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| WO2002094845A2 (en) | 2001-05-21 | 2002-11-28 | Intercell Ag | Method for stabilising of nucleic acids |
| AU2002358616A1 (en) | 2001-12-07 | 2003-06-17 | Intercell Ag | Immunostimulatory oligodeoxynucleotides |
| CA2522238A1 (en) * | 2003-04-15 | 2004-10-28 | Intercell Ag | S. pneumoniae antigens |
| EP1923069A1 (en) | 2006-11-20 | 2008-05-21 | Intercell AG | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| AU2009226949A1 (en) | 2008-03-17 | 2009-09-24 | Intercell Ag | Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
-
2009
- 2009-03-17 AU AU2009226949A patent/AU2009226949A1/en not_active Abandoned
- 2009-03-17 JP JP2011500189A patent/JP2011514167A/ja active Pending
- 2009-03-17 CA CA2718473A patent/CA2718473A1/en not_active Abandoned
- 2009-03-17 EP EP09723484A patent/EP2265634A2/en not_active Withdrawn
- 2009-03-17 CN CN2009801092188A patent/CN101977927A/zh active Pending
- 2009-03-17 US US12/933,020 patent/US8241643B2/en not_active Expired - Fee Related
- 2009-03-17 WO PCT/EP2009/053119 patent/WO2009115508A2/en not_active Ceased
- 2009-03-17 BR BRPI0909664A patent/BRPI0909664A2/pt not_active IP Right Cessation
-
2012
- 2012-08-03 US US13/565,990 patent/US8445001B2/en not_active Expired - Fee Related
-
2013
- 2013-04-17 US US13/864,642 patent/US20130280288A1/en not_active Abandoned